Patents by Inventor Devon M. Hunerdosse

Devon M. Hunerdosse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230406855
    Abstract: Imidazoquinoline compounds, salts thereof, conjugates thereof, pharmaceutical compositions containing the compounds and conjugates, and methods of use of such compounds as immune response modifiers, for inducing cytokine biosynthesis in humans and animals.
    Type: Application
    Filed: October 15, 2021
    Publication date: December 21, 2023
    Inventors: George W. Griesgraber, Mark A. Tomai, Hannah C. Cohen, Devon M. Hunerdosse
  • Publication number: 20230263462
    Abstract: A method and system for tissue impedance measurement are disclosed. In examples, the system comprises electrical contacts configured to be coupled to a first tissue and a first device configured to apply a first electrical signal to the first tissue via the electrical contacts. The system further comprises a second device configured to determine a first impedance phase angle of epithelial tissue of the first tissue site based on the first applied electrical signal, determine a baseline impedance phase angle of epithelial tissue corresponding to a second tissue, determine information indicative of epithelial tissue characteristics based on a ratio of the first impedance phase angle and the baseline impedance phase angle, and output information indicative of the epithelial tissue characteristics.
    Type: Application
    Filed: May 25, 2021
    Publication date: August 24, 2023
    Inventors: Stephen M. Kennedy, Jacob E. Odom, Jeffrey P. Kalish, Sean M. Sweetnam, Michael D. Benson, Jana Ninkovic, Devon M. Hunerdosse, Jason W. Bjork
  • Publication number: 20220194935
    Abstract: Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N-1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.
    Type: Application
    Filed: June 3, 2020
    Publication date: June 23, 2022
    Inventors: George W. Griesgraber, Hannah C. Cohen, Devon M. Hunerdosse, Kevin J. Bechtold
  • Publication number: 20220177471
    Abstract: Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N-1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing (or inhibiting) cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.
    Type: Application
    Filed: May 27, 2020
    Publication date: June 9, 2022
    Inventors: George W. Griesgraber, Michael J. Rice, Hannah C. Cohen, Devon M. Hunerdosse, Adam D. Miller, Joshua R. Wurst